Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (4)
  • Open Access

    ARTICLE

    Chicken Eggshell as an Innovative Bioflocculant in Harvesting Biofloc for Aquaculture Wastewater Treatment

    Hajjar Hartini Wan Jusoh1, Nor Azman Kasan2,*, Hidayah Manan2, Nurfarahana Mohd Nasir1,3, Fareza Hanis Mohd Yunos1, Sofiah Hamzah1, Ahmad Jusoh1,2,*

    Journal of Renewable Materials, Vol.11, No.5, pp. 2321-2332, 2023, DOI:10.32604/jrm.2023.026086

    Abstract Implementation of biofloc technology (BFT) system in aquaculture industry shows high productivity, low feed conversion ratio, and an optimum culture environment. This study was divided into two phases. The first phase involved maintaining the water quality using the optimum carbon-to-nitrogen ratio by manipulating pH in culture water. The second phase examined the performance of harvesting biofloc (remaining phytoplankton and suspended solids in the system) using chicken eggshell powder (CESP). This study showed that pH 7 to 8 were the best biofloc performance with high removal percentage of ammonia (>99%) with a remaining ammonia concentration of 0.016 mg L−1 and 0.018… More > Graphic Abstract

    Chicken Eggshell as an Innovative Bioflocculant in Harvesting Biofloc for Aquaculture Wastewater Treatment

  • Open Access

    ARTICLE

    The Use of as Natural Coagulant in Algerian Drinking Water Treatment Plant

    Abderrezzaq Benalia1,2, Kerroum Derbal2,*, Amel Khalfaoui1, Antonio Pizzi3, Ghouti Medjahdi4

    Journal of Renewable Materials, Vol.10, No.3, pp. 625-637, 2022, DOI:10.32604/jrm.2022.017848

    Abstract The purpose of this work is the study the ability of the plant material Aloe vera to act as natural coagulant using raw water obtained from a drinking water treatment plant (Mila, Algeria). Different solvents such as: NaCl; NaOH and HCl were used as chemical activators to extract the active components from the Aloe vera plant, and different coagulation-flocculation experiments were conducted in a jar test apparatus to evaluate the performance of the extracted coagulant. Also, the effect of coagulant dose on some water parameters such as turbidity, pH, total alkalinity and organic matter were investigated. The results showed that… More > Graphic Abstract

    The Use of  as Natural Coagulant in Algerian Drinking Water Treatment Plant

  • Open Access

    ARTICLE

    Chitosan and Carboxymethylchitosan as High Turbidity Water Biocoagulants

    Raimundo N. Lima Júnior1, João L. I. O. Almeida1, Jones de Andrade2, Flávia O. M. S. Abreu1,*

    Journal of Renewable Materials, Vol.8, No.11, pp. 1489-1504, 2020, DOI:10.32604/jrm.2020.011629

    Abstract Biocoagulants emerges as a promising technology in water treatment, in order to exploit renewable and biodegradable materials. The present work aims to study the coagulant action of chitosan and carboxymethylchitosan on water with very high turbidity (above 300 NTU), contrasting the physicochemical results with those obtained for aluminum sulphate. Carboxymethylchitosan was produced by the Williamson’s ethers synthesis and characterized by potentiometric titration, FTIR and 1 H-NMR. The coagulant tests were performed using synthetic water in a Jar-test equipment, through the induction of high and low velocity gradients, followed by sedimentation. The results showed turbidity and color removal efficiencies above 99%… More >

  • Open Access

    ARTICLE

    Novel oral anticoagulant use in adult Fontan patients: A single center experience

    Justin Georgekutty1, Amir Kazerouninia2, YunFei Wang3, Peter R. Ermis4, Dhaval R. Parekh4, Wayne J. Franklin4, Wilson W. Lam4

    Congenital Heart Disease, Vol.13, No.4, pp. 541-547, 2018, DOI:10.1111/chd.12603

    Abstract Objective: Adult Fontan patients are at increased risk for thrombosis and thromboembolic complications leading to increased morbidity and mortality. Most are prescribed antiplatelet or anticoagulant therapy for thromboprophylaxis; novel oral anticoagulants (NOACs) are uncommonly used given lack of data on their use in this population and generalized concerns regarding Fontan patients’ abnormal coagulation. We report the largest single-center experience with the use of NOACs for treatment and prophylaxis of thrombosis and thromboembolism in adult Fontan patients.
    Results: A retrospective chart review identified 21 patients (11 female, 10 male), median age 33 years (18-50) at first initiation, who were prescribed a… More >

Displaying 1-10 on page 1 of 4. Per Page